Skip to main content

1-20 of 145 results for member:"Matt Hancock"

Subject X
EU law

Type

House

Session

Year

Department

Member

Primary member

Answering member

Legislative stage

Legislation

Subject

More
EU law (145)

Publisher


Show detailed: On Off
Results: 10 20 50 100
Sort by: Newest first Oldest first

Second reading. Agreed to on question. Programme motion relating to proceedings in Public Bill Committee, on consideration and up to and including third reading. Agreed to on question. Money resolution. Agreed to on question. Ways and means resolution. Agreed to on question.

Lead member
Matt Hancock
Answering member
Jonathan Ashworth
Department
Department of Health and Social Care
Type
Debates on bills
Date
2 March 2020
Reference
672 cc658-710
House
House of Commons

I beg to move, That the Bill be now read a Second time.

While the world grapples with the challenge of coronavirus, it is vital that we do not lose sight of the important long-term reforms that we must make. Medicines and medical devices are evolving faster than ever. Not long...

Member
Matt Hancock (Conservative)
Type
Proceeding contributions
Date
2 March 2020
Reference
672 c659
House
House of Commons

We do not have a figure for medicines and medical devices specifically. As a nation, we have a goal that we should reach 2.4% of GDP spent on research. We are increasing the medical research budget; for instance, we are doubling the budget for research into dementia. As my right...

Member
Matt Hancock (Conservative)
Type
Proceeding contributions
Date
2 March 2020
Reference
672 c659
House
House of Commons

It is almost as though the hon. Gentleman has read my speech. That is the broad intent of that part of the Bill. I will come to it in more detail in a moment, and I am glad about the constructive tone that has been adopted across the House when...

Member
Matt Hancock (Conservative)
Type
Proceeding contributions
Date
2 March 2020
Reference
672 cc660-1
House
House of Commons

Yes, that is right. This Bill empowers us to be able to move faster. Essentially, it empowers the UK to build a life sciences regulatory framework that is the best in the world—of course, working with EU partners, but also with partners from right around the world—and all with the...

Member
Matt Hancock (Conservative)
Type
Proceeding contributions
Date
2 March 2020
Reference
672 c661
House
House of Commons

In some cases it was possible to share that information but not in all cases, and it will be possible now. I have no doubt that the hon. Member, like others on the frontline, will have received some information, but the MHRA is currently limited in the information that it...

Member
Matt Hancock (Conservative)
Type
Proceeding contributions
Date
2 March 2020
Reference
672 c662
House
House of Commons

I am sure that this debate will continue in Committee, but for clarity, those delegated powers existed under the European Communities Act 1972. The Bill proposes to replace existing delegated powers from the 1972 Act with new powers to make such regulations under the new Act. This is not a...

Member
Matt Hancock (Conservative)
Type
Proceeding contributions
Date
2 March 2020
Reference
672 c664
House
House of Commons
Member
Matt Hancock (Conservative)
Department
Department of Health and Social Care
Type
Government bills
Date
13 February 2020
Reference
Bill 90 2019-21
House
House of Commons

To ask the Secretary of State for Health and Social Care, whether he plans to reassess the requirements established by the European Medicines Agency guidelines implementing EU Directive 2001/83/EC on Medicinal Products for Human Use which specify that two species of mammal, one a non-rodent, must be used in repeated...

Asked by
David Amess (Conservative)
Answering body
Department of Health and Social Care
Type
Written questions
Status
Answered
Date
16 October 2018
Reference
175778
House
House of Commons

I beg to move, That the clause be read a Second time.

Member
Matt Hancock (Conservative)
Type
Proceeding contributions
Date
9 May 2018
Reference
640 c700
House
House of Commons

The Data Protection Bill sets out a full new data protection regime for Britain, giving people more control over their data.

First, I wish to address new clauses 20 and 21, before turning to the other new clauses. These new clauses are essentially the provisions contained in sections 40 and 42...

Member
Matt Hancock (Conservative)
Type
Proceeding contributions
Date
9 May 2018
Reference
640 c704
House
House of Commons

I will come on to what has changed in the many years since 2013, not least of which is the fact that we now have a full-blown independent press regulator, the Independent Press Standards Organisation, which did not exist back then.

Member
Matt Hancock (Conservative)
Type
Proceeding contributions
Date
9 May 2018
Reference
640 c704
House
House of Commons

We have three separate systems of media regulation in this country: a separate system for broadcasters; an essentially self-regulated system under IPSO for newspapers; and then there is the issue of how we make sure that what happens online is properly regulated as well. I will come on to that...

Member
Matt Hancock (Conservative)
Type
Proceeding contributions
Date
9 May 2018
Reference
640 c705
House
House of Commons

It did, yes. I am trying to ensure that we have a debate on these measures that takes into account the fact that, yes, we want a free press that can hold the powerful to account, but also that it is fair. I know—as does everyone in this House—that there...

Member
Matt Hancock (Conservative)
Type
Proceeding contributions
Date
9 May 2018
Reference
640 c705
House
House of Commons

My hon. Friend is completely right about the gap between online and print in terms of standards of regulation. That is because IPSO was brought into force—I was glad to see it being introduced in 2014. He is also right that tackling the problems online is critical. Our internet safety...

Member
Matt Hancock (Conservative)
Type
Proceeding contributions
Date
9 May 2018
Reference
640 c706
House
House of Commons

I have a lot of sympathy with the views of my hon. Friend. The MailOnline is, of course, an online publication, and we are looking at that as part of our internet safety strategy. I am very happy to talk to him about how that can be done. Only in...

Member
Matt Hancock (Conservative)
Type
Proceeding contributions
Date
9 May 2018
Reference
640 c706
House
House of Commons

That is absolutely right. The minimum access cost will be £50, which means that everybody has access to justice at low cost. There is more to it than that, however. Some people argue that the £60,000 limit on damages is too low, but the arbitration scheme does not stop somebody...

Member
Matt Hancock (Conservative)
Type
Proceeding contributions
Date
9 May 2018
Reference
640 c707
House
House of Commons

I agree with the sentiment, which is that we have to ensure that the press remains free but also fair and reasonable, and that is the purpose of the amendment proposing a review period of four years. We will not let matters lie.

Some have asked, “What happens if newspapers pull...

Member
Matt Hancock (Conservative)
Type
Proceeding contributions
Date
9 May 2018
Reference
640 c707
House
House of Commons

Given that this is a Data Protection Bill, the review will consider data protection issues, but I would expect it to be as broad as necessary, to ensure that all those matters are considered.

We have listened to concerns raised during the passage of the Bill, including in this debate.

Member
Matt Hancock (Conservative)
Type
Proceeding contributions
Date
9 May 2018
Reference
640 c707
House
House of Commons

On the contrary, the scheme introduces new, compulsory, low-cost arbitration to ensure that people can have exactly the recourse to justice mentioned by the right hon. Gentleman. In order to address some of the concerns, we have tabled two new clauses. First, new clause 19 requires the Information Commissioner to...

Member
Matt Hancock (Conservative)
Type
Proceeding contributions
Date
9 May 2018
Reference
640 c708
House
House of Commons